U.S., July 7 -- ClinicalTrials.gov registry received information related to the study (NCT07685275) titled 'Real-Time Mass Spectrometry Breath Analysis for the Investigation of Respiratory Tract Infections' on June 29.
Brief Summary: Lower respiratory tract infections (LRTIs) remain a major global health burden, with diagnosis often challenged by clinical heterogeneity, overlapping symptoms, difficulty in obtaining quality biological specimens and limitations of conventional microbiological testing. Exhaled breath contains thousands of volatile organic compounds (VOCs), arising from both host metabolism and microbial activity, and provides a non-invasive window into the metabolic landscape of infection. Emerging evidence from in vitro stud...